NKPD1: Key Regulator of NK Cells and Cellular Processes (G284353)
NKPD1: Key Regulator of NK Cells and Cellular Processes
NKPD1 (NKPD1_HUMAN) is a protein that is expressed in most human tissues and is involved in the immune response. It is a key regulator of natural killer cells (NK cells), which are a crucial part of the immune system that help to fight off infections and diseases.
NKPD1 is a protein that is expressed in most human tissues and is involved in the immune response.
One of the key functions of NKPD1 is its role in regulating the activity of NK cells. NK cells are a crucial part of the immune system, as they are able to detect and respond to the presence of foreign or abnormal cells in the body. NKPD1 helps to ensure that NK cells are able to recognize and destroy these cells without getting overwhelmed by the body's immune response.
Another important function of NKPD1 is its role in regulating the production of new cells in the body. NKPD1 helps to ensure that the body has enough healthy immune cells to fight off infections and diseases. It does this by regulating the production of new NK cells in the bone marrow, which is the spongy tissue that is found inside the bones.
In addition to its role in regulating the immune system, NKPD1 is also involved in the regulation of cellular processes in the body. For example, NKPD1 has been shown to be involved in the regulation of cell death, as well as the control of cell proliferation.
Given its involvement in so many important functions in the body, it is not surprising that NKPD1 has become a drug target for researchers. Many scientists are working to develop drugs that can inhibit the activity of NKPD1 in order to treat a variety of diseases.
One of the most promising areas of research is the use of NKPD1 as a drug target for cancer. NKPD1 has been shown to be involved in the regulation of cell death in cancer cells, which may make it an attractive target for cancer treatments. Researchers are currently working to develop drugs that can inhibit the activity of NKPD1 in cancer cells, with the goal of using these drugs to treat a variety of cancer types.
Another promising area of research is the use of NKPD1 as a biomarker for disease. NKPD1 is expressed in many different tissues in the body, which makes it an attractive target for use as a biomarker. Researchers are currently using NKPD1 as a biomarker to diagnose and monitor a variety of diseases, including cancer, HIV, and hepatitis.
Overall, NKPD1 is a protein that is involved in many important functions in the body, including the regulation of the immune system and the regulation of cellular processes. As a result, it is an attractive target for drug development and use as a biomarker in the diagnosis and treatment of a variety of diseases.
Protein Name: NTPase KAP Family P-loop Domain Containing 1
The "NKPD1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NKPD1 comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
NKRF | NKTR | NKX1-1 | NKX1-2 | NKX2-1 | NKX2-1-AS1 | NKX2-2 | NKX2-3 | NKX2-4 | NKX2-5 | NKX2-6 | NKX2-8 | NKX3-1 | NKX3-2 | NKX6-1 | NKX6-2 | NKX6-3 | NLE1 | NLGN1 | NLGN1-AS1 | NLGN2 | NLGN3 | NLGN4X | NLGN4Y | NLK | NLN | NLRC3 | NLRC4 | NLRC4 Inflammasome | NLRC5 | NLRP1 | NLRP1 Inflammasome | NLRP10 | NLRP11 | NLRP12 | NLRP13 | NLRP14 | NLRP2 | NLRP2B | NLRP3 | NLRP3 Inflammasome | NLRP3P1 | NLRP4 | NLRP5 | NLRP6 | NLRP7 | NLRP8 | NLRP9 | NLRP9P1 | NLRX1 | NMB | NMBR | NMD3 | NMDA receptor | NME1 | NME1-NME2 | NME2 | NME2P1 | NME3 | NME4 | NME5 | NME6 | NME7 | NME8 | NME9 | NMI | NMNAT1 | NMNAT2 | NMNAT3 | NMRAL1 | NMRAL2P | NMRK1 | NMRK2 | NMS | NMT1 | NMT2 | NMTRQ-TTG10-1 | NMTRQ-TTG12-1 | NMTRV-TAC1-1 | NMU | NMUR1 | NMUR2 | NNAT | NNMT | NNT | NNT-AS1 | NOA1 | NOB1 | NOBOX | NOC2L | NOC2LP2 | NOC3L | NOC4L | NOCT | NOD1 | NOD2 | NODAL | NOG | NOL10 | NOL11
